Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity.
about
Modelling clinical systemic lupus erythematosus: similarities, differences and success storiesArtery Tertiary Lymphoid Organs Control Multilayered Territorialized Atherosclerosis B-Cell Responses in Aged ApoE-/- Mice.Mechanisms of Autoantibody-Induced Pathology.The immunosignature of canine lymphoma: characterization and diagnostic applicationPersistent autoantibody-production by intermediates between short-and long-lived plasma cells in inflamed lymph nodes of experimental epidermolysis bullosa acquisitaEosinophils and megakaryocytes support the early growth of murine MOPC315 myeloma cells in their bone marrow nichesLong-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors.Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosusBortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice.West Nile virus IgM and IgG antibodies three years post- infection.Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr miceLong-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche.Hypersensitivity reactions to corticosteroids.Autoimmunity in 2012.Plasma cells in immunopathology: concepts and therapeutic strategies.Bone marrow analysis of immune cells and apoptosis in patients with systemic lupus erythematosus.Plasma cells as an innovative target in autoimmune disease with renal manifestations.Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus.Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.Maintenance of CD8(+) memory T lymphocytes in the spleen but not in the bone marrow is dependent on proliferation.HM71224, a selective Bruton's tyrosine kinase inhibitor, attenuates the development of murine lupus.Upregulation of FcγRIIB by resveratrol via NF-κB activation reduces B-cell numbers and ameliorates lupus.Peripheral CD24hi CD27+ CD19+ B cells subset as a potential biomarker in naïve systemic lupus erythematosus.[Immunological memory of the bone marrow].Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.[Therapy-resistant cells of the B cell line].
P2860
Q28074217-5B8F618A-0B00-4C17-A6CA-B23DECC081D6Q30276940-EE8C24BA-30B8-4675-9931-13D80C18B57FQ33740580-1EFCFC2E-7F17-4776-BD9D-EBA0FCBDD243Q34208766-15BB55EE-C961-49E8-9523-1B46C3674B2AQ35080528-D0FCC836-5105-4B9C-9C37-E5D162FD41DFQ35291672-BD5F7DAE-9138-43CA-8815-983AC217FD57Q35544326-F650B467-68B3-497D-9710-28917597C71BQ35577284-F61A9C57-CCC7-4F78-82A6-49FF5308429AQ35739625-D2216DB8-341E-4F17-A47D-BBEB16468F32Q36071951-BBE2BA9B-82A0-438A-B1D3-6F6E0D17D559Q36254552-9C9B7577-4A41-4EA1-AC19-757AFE6EAF12Q37662690-FC81274C-2E85-41E8-B949-E8F5BE29CEB8Q38097320-D72E9D06-2E6D-49D8-B9A9-44A487CD3D4AQ38131447-256A875B-37C8-4E11-92E5-BD4CB4EC852DQ38205130-3E074B98-710C-4D1E-B7AB-2413913211C1Q38438936-53E639A9-D015-412D-9144-83E9C2F24BC6Q38753491-9EB42ABB-90D2-4EBC-8D43-F38F97443FC8Q39303557-D068E473-CB31-4BB2-9B53-F682A8804089Q39335102-3E7FD05C-EB2C-4CB8-B16C-E465ED9C443BQ40090495-B45264A7-FE26-4319-B4F2-C6624DCBFCA5Q41670053-654C71A5-1A15-494D-964D-AD63FED04BEFQ42370436-D3F8BC5F-D236-4318-82EE-3B0537A611B6Q43948799-2F48DF4D-394E-40AF-AFDE-1D0D888BC122Q50716469-4D4ED719-3BA3-47DB-89F1-BDE4C9E9216CQ50919840-24EBACD9-94A7-47E5-AEBA-55E88B2669DBQ52850241-BC97CDCB-454A-4203-8877-41A5B6C3F1BC
P2860
Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Bone marrow of NZB/W mice is t ...... the treatment of autoimmunity.
@en
Bone marrow of NZB/W mice is t ...... the treatment of autoimmunity.
@nl
type
label
Bone marrow of NZB/W mice is t ...... the treatment of autoimmunity.
@en
Bone marrow of NZB/W mice is t ...... the treatment of autoimmunity.
@nl
prefLabel
Bone marrow of NZB/W mice is t ...... the treatment of autoimmunity.
@en
Bone marrow of NZB/W mice is t ...... the treatment of autoimmunity.
@nl
P2093
P1476
Bone marrow of NZB/W mice is t ...... the treatment of autoimmunity
@en
P2093
Andreas Radbruch
Daniel Panne
Falk Hiepe
Gerd-R Burmester
Imtiaz M Mumtaz
Katrin Moser
Oliver Winter
Qingyu Y Cheng
Rudolf A Manz
Taketoshi Yoshida
P304
P356
10.1016/J.JAUT.2012.05.010
P50
P577
2012-06-20T00:00:00Z